Cerulean Pharma reported $16.05M in Current Liabilities for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Arrowhead Research ARWR:US $ 138.86M 1.82M
Bayer BAYN:GR € 29403M 676M
Brainstorm Cell Therapeutics BCLI:US $ 7.37M 1.06M
Cerulean Pharma CERU:US $ 16.05M 0.15M
Immunogen IMGN:US $ 84.12M 16.83M
Nektar Therapeutics NKTR:US $ 85.2M 54.77M